… The chronic treatment of Parkinson's disease with l-dopa is often … treatment of the slowness
of movement, increased muscle tone, and tremor that are typical of Parkinson's disease. Why …

… L-Dopa remains the gold standard for the treatment of PD because of its impressive efficacy
on the motor symptoms of parkinsonism and because of its relatively cheap price. When …

… However, currently, drug therapy cannot completely cure the disease. DA replacement
therapy with levodopa (L-Dopa), although still being a gold standard for symptomatic treatment of …

… , and (10) a review of PD medical and surgical treatments. Motor scores for the Unified
Parkinson's Disease Rating Scale (UPDRS) were collected for each patient. Individual item …

… specific and sensitive biomarkers, the diagnosis of Parkinson's disease (PD) is still based on
… Levodopa therapy remains the gold standard in the management of motor features of PD. …

… Parkinson’s Disease Multidisciplinary Complex Treatment” program in which pharmacological
treatment … , occupational therapy, speech and language therapy, specialized balance and …

… the 1960s, and levodopa was developed as a drug that improves both the symptoms and
life prognosis of patients (1). This drug is still the gold standard for treating PD. However, by the …

… in advanced Parkinson's disease. In the early 2010s, levodopa remains the gold standard. …
door for novel nondopaminergic approaches of Parkinson's disease therapy. More recently, …

… therapeutic interventions. To date, clinical assessment remains the gold standard in the
diagnosis of Parkinson’s disease … rate of clinical decline in Parkinson disease. Arch Neurol 2009; …

… the gold standard for treating gastrointestinal symptoms in patients with Parkinsons disease
(PD) because the risk of developing extrapyramidal adverse effects is considered minimal. …